8-K – Page 560 – China Stock Advice

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[SHARE TRANSFER CONTRACT OF SHAANXI WEINAN HUAREN PHARMACEUTICALS CO., LTD. BY AND BETWEEN SHAANXI AOXING PHARMACEUTICALS CO., LTD. AND SHAREHOLDERS OF SHAANXI WEINAN HUAREN PHARMACEUTICALS CO., LTD. INDEX CHAPATER I DEFINITION AND INTERPRETATION 4 ARTICLE 1 DEFINITION 4 CHAPATER II TRANSFERRED SHARES 5 ARTICLE 2 SHARE TRANSFER 5 ARTICLE 3 TRANSFER PRICE 5 ARTICLE 4 CONDITIONS FOR THE PAYMENT OF] [Form Non-competition Agreement Agreement This Non-competition Agreement (this “ Party A: Shaanxi Weinan Huaren Pharmaceuticals Co., Ltd., a company incorporated under PRC law, with its business license registered number [_] and its legal address registered at No. 13, Weihua Road, Weinan City, Shaanxi Province; Party B: [_], a PRC citizen with the ID number [_]. Whereas Equity Interests Article 1] [BIOSTAR PHARMACEUTICALS SIGNS AGREEMENT TO ACQUIRE SHAANXI WEINAN HUAREN PHARMACEUTICALS, LTD . XIANYANG, China, October 11, 2011 -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a developer, manufacturer and marketer of pharmaceutical and health supplement products for a variety of diseases and conditions, today announced that its wholly owned subsidiary, Shaanxi Aoxing Pharmaceutical, Ltd., entered into a]

By info| 2016-03-03T12:28:51+00:00 October 11th, 2011|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 2011-10-11, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: SHARE TRANSFER CONTRACT OF SHAANXI WEINAN HUAREN PHARMACEUTICALS

[SHARE TRANSFER CONTRACT OF SHAANXI WEINAN HUAREN PHARMACEUTICALS CO., LTD. BY AND BETWEEN SHAANXI AOXING PHARMACEUTICALS CO., LTD. AND SHAREHOLDERS OF SHAANXI WEINAN HUAREN PHARMACEUTICALS CO., LTD. INDEX CHAPATER I DEFINITION AND INTERPRETATION 4 ARTICLE 1 DEFINITION 4 CHAPATER II TRANSFERRED SHARES 5 ARTICLE 2 SHARE TRANSFER 5 ARTICLE 3 TRANSFER PRICE 5 ARTICLE 4 CONDITIONS FOR THE PAYMENT OF] [Form Non-competition Agreement Agreement This Non-competition Agreement (this “ Party A: Shaanxi Weinan Huaren Pharmaceuticals Co., Ltd., a company incorporated under PRC law, with its business license registered number [_] and its legal address registered at No. 13, Weihua Road, Weinan City, Shaanxi Province; Party B: [_], a PRC citizen with the ID number [_]. Whereas Equity Interests Article 1] [BIOSTAR PHARMACEUTICALS SIGNS AGREEMENT TO ACQUIRE SHAANXI WEINAN HUAREN PHARMACEUTICALS, LTD . XIANYANG, China, October 11, 2011 -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a developer, manufacturer and marketer of pharmaceutical and health supplement products for a variety of diseases and conditions, today announced that its wholly owned subsidiary, Shaanxi Aoxing Pharmaceutical, Ltd., entered into a]

By info| 2016-03-03T12:30:06+00:00 October 11th, 2011|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 2011-10-11, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[SHARE TRANSFERNTRACT OF SHAANXI WEINAN HUAREN PHARMACEUTICALS BY AND BETWEEN SHAANXI AOXING PHARMACEUTICALS AND SHAREHOLDERS OF SHAANXI WEINAN HUAREN PHARMACEUTICALS INDEX CHAPATER I DEFINITION AND INTERPRETATION 4 ARTICLE 1 DEFINITION 4 CHAPATER II TRANSFERRED SHARES 5 ARTICLE 2 SHARE TRANSFER 5 ARTICLE 3 TRANSFER PRICE] [Form Non-competitionreementreement This Non-competitionreement (this Party A:Shaanxi Weinan Huaren Pharmaceuticals ampanyorporated under law, with its business license registered number [_] and its legaldress registered at No. 13, Weihua Road, Weinan City, Shaanxi Province; Party B:[_], a citizen with the ID number [_].] [BIOSTAR PHARMACEUTICALS SIGNSREEMENT TO ACQUIRE SHAANXI WEINAN HUAREN PHARMACEUTICALS, . XIANYANG, China, October 11, 2011 -- Biostar Pharmaceuticals, (NASDAQ GM: BSPM) ("Biostar" or "thempany"), a developer, manufacturer and marketer of pharmaceutical and health supplement products for a variety of diseases andnditions, today announced that its wholly owned subsidiary, Shaanxi Aoxing Pharmaceutical, entered into a Share]

By info| 2016-02-07T16:04:02+00:00 October 11th, 2011|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 2011-10-11, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: SHARE TRANSFERNTRACT OF SHAANXI WEINAN HUAREN PHARMACEUTICALS BY

[SHARE TRANSFERNTRACT OF SHAANXI WEINAN HUAREN PHARMACEUTICALS BY AND BETWEEN SHAANXI AOXING PHARMACEUTICALS AND SHAREHOLDERS OF SHAANXI WEINAN HUAREN PHARMACEUTICALS INDEX CHAPATER I DEFINITION AND INTERPRETATION 4 ARTICLE 1 DEFINITION 4 CHAPATER II TRANSFERRED SHARES 5 ARTICLE 2 SHARE TRANSFER 5 ARTICLE 3 TRANSFER PRICE] [Form Non-competitionreementreement This Non-competitionreement (this Party A:Shaanxi Weinan Huaren Pharmaceuticals ampanyorporated under law, with its business license registered number [_] and its legaldress registered at No. 13, Weihua Road, Weinan City, Shaanxi Province; Party B:[_], a citizen with the ID number [_].] [BIOSTAR PHARMACEUTICALS SIGNSREEMENT TO ACQUIRE SHAANXI WEINAN HUAREN PHARMACEUTICALS, . XIANYANG, China, October 11, 2011 -- Biostar Pharmaceuticals, (NASDAQ GM: BSPM) ("Biostar" or "thempany"), a developer, manufacturer and marketer of pharmaceutical and health supplement products for a variety of diseases andnditions, today announced that its wholly owned subsidiary, Shaanxi Aoxing Pharmaceutical, entered into a Share]

By info| 2016-02-07T16:04:35+00:00 October 11th, 2011|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 2011-10-11, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

HPJ [Highpower International] 8-K: (Original Filing)

[th 30 100 F Street, N.E. Re: Highpower International, Inc. Commissioners: th Sincerely, Dominic K. F. Chan & Co. Certified Public Accountants th Hong Kong, 30] [Delaware 001-34098 20-4062622 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) Building A1, Luoshan Industrial Zone, Shanxia, Pinghu, Longgang, Shenzhen, Guangdong, 518111, China (86) 755-89686238 (Former name or former address, if changed since last report.) ¨ ¨ ¨ ¨ Item 4.01 On September 30, 2011 Highpower International, Inc. (the “Company”) dismissed Dominic K.F. Chan & Co. (“DKFC”) as]

By info| 2016-03-14T10:20:08+00:00 October 6th, 2011|Categories: Chinese Stocks, HPJ, SEC Original|Tags: 0001368308, 2011-10-06, 3690, 8-K, HPJ, MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT and SUPPLIES|0 Comments

CBPO [China Biologic Products] 8-K: (Original Filing)

[CHINA BIOLOGIC PRODUCTS, INC. INDEPENDENT DIRECTOR AGREEMENT Agreement Company Director THIS AGREEMENT (The BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy and to have the Director perform the duties of an independent director and the Director desires to be so appointed for such position and to perform the duties] [INDEMNIFICATION AGREEMENT Company Indemnitee This Indemnification Agreement, dated as of October 6, 2011, is made by and between China Biologic Products, Inc., a Delaware corporation (the RECITALS A. The Company and the Indemnitee recognize that the present state of the law is too uncertain to provide the Companys officers and directors with adequate and reliable advance knowledge or guidance] [Company contact Mr. Y. Tristan Kuo China Biologic Announces Changes in Directors BEIJING, October 6, 2011 /PRNewswire/ China Biologic Products, Inc. (NASDAQ: CBPO, “China Biologic” or the “Company”), one of the leading plasma-based biopharmaceutical companies in the People’s Republic of China, today announced two changes in its board of directors. On October 6, 2011, Dr. Xiangmin Cui resigned from his] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): October 6, 2011 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai'an City, Shandong, 271000 People's Republic of China 86-538 -620-2306 (Former name or former address, if changed since]

By info| 2016-04-03T03:01:12+00:00 October 6th, 2011|Categories: CBPO, Chinese Stocks, SEC Original|Tags: 0001369868, 2011-10-06, 2836, 8-K, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments

HPJ [Highpower International] 8-K: th 30 100 F Street, N.E. Re: Highpower

[th 30 100 F Street, N.E. Re: Highpower International, Inc. Commissioners: th Sincerely, Dominic K. F. Chan & Co. Certified Public Accountants th Hong Kong, 30] [Delaware 001-34098 20-4062622 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) Building A1, Luoshan Industrial Zone, Shanxia, Pinghu, Longgang, Shenzhen, Guangdong, 518111, China (86) 755-89686238 (Former name or former address, if changed since last report.) ¨ ¨ ¨ ¨ Item 4.01 On September 30, 2011 Highpower International, Inc. (the “Company”) dismissed Dominic K.F. Chan & Co. (“DKFC”) as]

By info| 2016-03-14T10:21:19+00:00 October 6th, 2011|Categories: Chinese Stocks, HPJ, Webplus ver|Tags: 0001368308, 2011-10-06, 3690, 8-K, HPJ, MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT and SUPPLIES|0 Comments

CBPO [China Biologic Products] 8-K: CHINA BIOLOGIC PRODUCTS, INC. INDEPENDENT DIRECTOR AGREEMENT Agreement

[CHINA BIOLOGIC PRODUCTS, INC. INDEPENDENT DIRECTOR AGREEMENT Agreement Company Director THIS AGREEMENT (The BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy and to have the Director perform the duties of an independent director and the Director desires to be so appointed for such position and to perform the duties] [INDEMNIFICATION AGREEMENT Company Indemnitee This Indemnification Agreement, dated as of October 6, 2011, is made by and between China Biologic Products, Inc., a Delaware corporation (the RECITALS A. The Company and the Indemnitee recognize that the present state of the law is too uncertain to provide the Companys officers and directors with adequate and reliable advance knowledge or guidance] [Company contact Mr. Y. Tristan Kuo China Biologic Announces Changes in Directors BEIJING, October 6, 2011 /PRNewswire/ China Biologic Products, Inc. (NASDAQ: CBPO, “China Biologic” or the “Company”), one of the leading plasma-based biopharmaceutical companies in the People’s Republic of China, today announced two changes in its board of directors. On October 6, 2011, Dr. Xiangmin Cui resigned from his] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): October 6, 2011 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai'an City, Shandong, 271000 People's Republic of China 86-538 -620-2306 (Former name or former address, if changed since]

By info| 2016-04-03T03:02:46+00:00 October 6th, 2011|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: 0001369868, 2011-10-06, 2836, 8-K, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)

[TPI Announces Fiscal Year 2011 Financial Results September 27, 2011 Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals, announced the financial results for the Fiscal Year 2011. Fiscal year 2011 ending June 30, 2011 financial highlights Revenue delivered $95.2 million, exceeding the guided $90.0] [Tianyin Pharmaceutical Inc. Fiscal Year 2011 Annual Financial Results Conference Call September 27, 2011 Operator: During today’s presentation, all parties will be in a listen-only mode. Following the presentation, the conference will be opened for questions. If you have a question, please press the star, followed by the one on your touchtone phone. If you would like to withdraw your] []

By info| 2016-03-27T20:14:04+00:00 October 4th, 2011|Categories: Chinese Stocks, SEC Original, TPI|Tags: 0001362718, 2011-10-04, 2834, 8-K, PHARMACEUTICAL PREPARATIONS, TPI|0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: TPI Announces Fiscal Year 2011 Financial Results September

[TPI Announces Fiscal Year 2011 Financial Results September 27, 2011 Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals, announced the financial results for the Fiscal Year 2011. Fiscal year 2011 ending June 30, 2011 financial highlights Revenue delivered $95.2 million, exceeding the guided $90.0] [Tianyin Pharmaceutical Inc. Fiscal Year 2011 Annual Financial Results Conference Call September 27, 2011 Operator: During today’s presentation, all parties will be in a listen-only mode. Following the presentation, the conference will be opened for questions. If you have a question, please press the star, followed by the one on your touchtone phone. If you would like to withdraw your] []

By info| 2016-03-27T20:15:17+00:00 October 4th, 2011|Categories: Chinese Stocks, TPI, Webplus ver|Tags: 0001362718, 2011-10-04, 2834, 8-K, PHARMACEUTICAL PREPARATIONS, TPI|0 Comments